Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
betamethasone + gentamicin
- Development stage
- Unknown
- Lead developer
- Akrikhin
- Modality
- Small Molecules
- Administration
- Topical
01
Overview
Acriderm Genta is a topical combination dermatological preparation containing the synthetic corticosteroid betamethasone dipropionate and the aminoglycoside antibiotic gentamicin sulfate. Developed by Akrikhin, it is used for the treatment of inflammatory skin disorders (such as eczema, dermatitis, and psoriasis) complicated by secondary bacterial infections susceptible to gentamicin. Betamethasone dipropionate provides anti-inflammatory, antipruritic, and vasoconstrictive actions, while gentamicin sulfate provides broad-spectrum bactericidal activity against susceptible bacteria.
- Brand names
- Acriderm Genta
- Other names
- betamethasone dipropionate + gentamicin sulfatebetamethasone valerate + gentamicin sulfategentamicin + betamethasone
02
Targets
Bacterial 16S ribosomal RNA decoding siteGR (Glucocorticoid receptor)
Beyond the preview
Go deeper on betamethasone + gentamicin.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on betamethasone + gentamicin.